Showing results (1-10 of 554) with videos related to

Sort By:
Pageof 56
International Journal of Urology : Official Journal of the Japanese Urological Association|October 17, 2009
Oncolytic virus therapy for prostate cancerHiroshi Fukuhara, Yukio Homma, Tomoki Todo
International Journal of Urology : Official Journal of the Japanese Urological Association|March 23, 2017
Current status of clinical trials assessing oncolytic virus therapy for urological cancersSatoru Taguchi, Hiroshi Fukuhara, Yukio Homma, et al.
Current Cancer Drug Targets|March 10, 2007
Oncolytic herpes simplex virus type 1 and host immune responsesHiroshi Fukuhara, Tomoki Todo
Japanese Journal of Clinical Oncology|November 22, 2018
Oncolytic virus therapy in Japan: progress in clinical trials and future perspectivesSatoru Taguchi, Hiroshi Fukuhara, Tomoki Todo
Cancer Science|August 4, 2016
Oncolytic virus therapy: A new era of cancer treatment at dawnHiroshi Fukuhara, Yasushi Ino, Tomoki Todo
Cancer Science|May 26, 2021
Triple-mutated oncolytic herpes virus for treating both fast- and slow-growing tumorsHiroshi Fukuhara, Yuta Takeshima, Tomoki Todo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacyYasushi Ino, Yoshinaga Saeki, Hiroshi Fukuhara, et al.
Communications Medicine|March 25, 2023
Fusion peptide is superior to co-expressing subunits for arming oncolytic herpes virus with interleukin 12Hiroshi Fukuhara, Yuzuri Tsurumaki Sato, Jiangang Hou, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 12, 2016
Direct influence of systemic desensitization by resiniferatoxin on the activities of Aδ- and C-fibers in the rat primary bladder mechanosensitive afferent nervesNaoki Aizawa, Hiroshi Fukuhara, Tetsuya Fujimura, et al.
Pageof 56